Skip to main content

IPO Chilli Ratings

IPO Chilli Ratings
Click to understand how it works

Featured

Singapore Institute of Advanced Medicine Holdings Ltd

Singapore Institute of Advanced Medicine Holdings Ltd ("Sam" or the "Company") is offering 114m new shares comprising 4.415m Public Offer Shares and 109.585m Placement Shares at $0.23 each for a listing on Catalist.  The Company aims to raise $26.2m and the majority of the proceeds will be used to repay debt and the balance for working capital. The market cap based on the IPO price is $231.8m and the offer will close on 14 Feb at 12 noon and starts trading on 16 Feb 2024 at 9am.   Principal Business SAM is a healthcare service provider using advanced technology for early and accurate diagnosis to detect and treat cancer, neurodegenerative and cardiovascular diseases.  SAM has strategic collaborations with public and private institutions for research and clinical work.  SAM's goal is to create a comprehensive one-stop ambulatory cancer centre to undertake the challenges to fight cancer and is one of the first to adopt proto beam therapy treatment in Singapore. Fi

Parkway REIT debuts below IPO price

(Source: Today Newspaper dated 24 Aug 2007)

I believed those who received the shares through balloting must be wondering if they are 'lucky' to get it because they could have bought the shares at a cheaper price from the open market on its debut. If a 'stable and bluechip' REIT also opens below the debut price, i doubt underwriters will dare to bring any BIG float ipo to the market in the short term. More likely smallish IPOs will be used to test the market sentiment first as it is easier to place out and 'control' the smaller float.
I guess i can take a 'prolonged' holiday in the meantime...

Comments